NovoCure (NVCR) Assets Growth (5y) (2019 - 2026)
NovoCure (NVCR) Assets Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.23% |
| Mar 31, 2026 | -5.89% |
| Dec 31, 2025 | -5.23% |
| Sep 30, 2025 | 25.86% |
| Jun 30, 2025 | 18.69% |
| Mar 31, 2025 | 19.97% |
| Dec 31, 2024 | 20.95% |
| Sep 30, 2024 | 22.45% |
| Jun 30, 2024 | 24.44% |
| Mar 31, 2024 | 24.81% |
| Dec 31, 2023 | 27.53% |
| Sep 30, 2023 | 29.44% |
| Jun 30, 2023 | 30.19% |
| Mar 31, 2023 | 31.08% |
| Dec 31, 2022 | 35.05% |
| Sep 30, 2022 | 34.96% |
| Jun 30, 2022 | 35.24% |
| Mar 31, 2022 | 34.16% |
| Dec 31, 2021 | 32.21% |
| Sep 30, 2021 | 30.94% |